Hepatic Angiosarcoma

Overview


Plain-Language Overview

Hepatic Angiosarcoma is a rare and aggressive cancer that starts in the blood vessels of the liver. It affects the liver, an important organ responsible for filtering toxins and producing vital proteins. This cancer grows quickly and can cause symptoms like abdominal pain, swelling, and unexplained weight loss. Because it involves the blood vessels, it can lead to bleeding inside the liver and spread to other parts of the body. Diagnosis is often challenging, and the disease usually progresses rapidly, impacting overall health severely.

Clinical Definition

Hepatic Angiosarcoma is a malignant tumor arising from the endothelial cells lining the hepatic blood vessels. It is characterized by aggressive, infiltrative growth and a high propensity for vascular invasion and metastasis. The pathogenesis often involves exposure to carcinogens such as vinyl chloride, arsenic, and thorotrast. Clinically, it presents with nonspecific symptoms including hepatomegaly, abdominal pain, and signs of liver failure. Histologically, it shows irregular, anastomosing vascular channels lined by atypical endothelial cells. The tumor is highly aggressive with poor prognosis due to late diagnosis and limited effective treatment options.

Clinical Presentation


Diagnostic Workup


Pathophysiology


Treatments


Prevention


Outcome & Complications


Differential Diagnoses


Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

Analytics Disclosure: If you allow analytics cookies, Doctogenic uses Google Analytics, Microsoft Application Insights, and Microsoft Clarity to understand site usage, diagnose issues, review heatmaps and session replay recordings, and improve the service on pages where those tools are enabled. Clarity is not enabled on account, purchase, billing, checkout, Stripe-related, or admin pages. You can change this choice through Cookie preferences.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.